Nariman Medhora's Insider Trades & SAST Disclosures
Nariman Medhora's most recent trade in Fredun Pharmaceuticals Ltd. was a Acquisition of 144,515 Equity Shares done at an average price of Rs. 422.1 . Disclosure was reported to the exchange on Nov. 25, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Nariman Medhora in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fredun Pharma | Nariman Medhora | Promoter & Director | Acquisition | 25 Nov 2021 | 144,515 | 719,815 (16.24%) | 3.62% | 422.1 | 60,999,782 | 23 Nov 2021 23 Nov 2021 |
Insider Trading | Equity Shares | Allotment |
| Fredun Pharma | Nariman Medhora | Promoter & Director | Acquisition | 22 Nov 2021 | 144,515 | 144,515 (3.25%) | 3.62% | 422.1 | 60,999,782 | 17 Nov 2021 17 Nov 2021 |
Insider Trading | Warrants | Allotment |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.